Blog
19 Articles
AVENGER 500 Clinical Trial Shows No Overall Survival Benefit
Data from the AVENGER 500 clinical trial explains why the trial’s goal was not met. A new trial with a different approach has launched.
Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer
Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.
Targeting Pancreatic Cancer Cell Growth
Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.
Brain Cancer Vaccine for Metastatic PNET
Researchers are testing a vaccine for PNET that targets a protein that is very abundant in many neuroendocrine tumors.
Research Updates from ASCO GI 2023
Read the latest clinical trial and research updates from the 2023 ASCO GI meeting, including a review of genetic testing uptake.
Hypertension Drug as Part of First-Line Treatment for Unresectable Pancreatic Cancer
Researchers are testing if the addition of a hypertension drug to standard treatment will be more effective for advanced pancreatic cancer.
Chemotherapy-Radiation Combination for Pancreatic Cancer in the Liver
Can targeted radiation disrupt tumor growth in the liver of advanced pancreatic cancer patients with BRCA2 and PALB2 mutations?
Testing a Combination for Metastatic Pancreatic Cancer
A clinical trial tests an investigational drug, immunotherapy, and radiation in combination against advanced pancreatic cancer.
A New Vaccine for Advanced Pancreatic Cancer
An mRNA vaccine that works against KRAS mutations is being tested with and without immunotherapy for advanced or metastatic pancreatic cancer.
Safety and Effectiveness of a New Drug for Advanced Pancreatic Cancer
Researchers are testing dose safety and effectiveness of a new drug for pancreatic cancer, in combination with gemcitabine.
Testing the Safety of an Immunotherapy Combination After Surgery
A new clinical trial tests the safety of a monoclonal antibody and personalized cancer vaccine plus chemotherapy after surgery to remove pancreatic cancer.
Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers
Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.
Immunotherapy to Attack a Common Pancreatic Cancer Mutation
Researchers are testing a type of immunotherapy to attack a variant of the KRAS mutation; KRAS mutations occur in almost all pancreatic cancers.
Targeting Cancer-Associated Wasting With Experimental Immunotherapy
Wasting, or cachexia, is the focus of a clinical trial testing a cachexia immunotherapy treatment combined with standard pancreatic cancer treatment.
Targeting Tumor Proteins Specific to Pancreatic Cancer Cells
A clinical trial tests the safety and effectiveness of tumor-associated antigen-specific cytotoxic T lymphocytes, which target specific tumor proteins.